Type to search

BHT Announces Positive Results from Osteopenia Treatment | PTF
Ionis Announces European Medicines Agency Accepts Marketing Authorization Application of Tofersen to Treat Rare, Genetic form of ALS | PTF
Syndax Announces U.S. FDA Breakthrough Therapy Designation Granted for Patients with Relapsed or Refractory KMT2A- Rearranged (MLLr) Acute Leukemia | PTF